Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
What has been your experience with JAK/STAT inhibitors for granuloma annulare?
Related Questions
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
How do you approach a patient with stoma bag adhesive allergic contact dermatitis?
What alternative medications other than dapsone would you consider for dermatitis herpetiformis in a sulfa-allergic patient?
How do you approach treatment escalation to systemic agents for erythromelalgia, after treating with topicals and trigger avoidance?
What concentration of TCA is typically used to treat porokeratosis on the arms and legs?
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
Have you encountered idiopathic aseptic facial granuloma in areas other than the face?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
